This announcement is a separate document:
金河生物：上海信公轶禾企业管理咨询有限公司关于金河生物科技股份有限公司2024年股票期权激励计划授予相关事项之独立财务顾问报告
Jinhe Biotechnology: Independent financial advisor report on the granting of stock options under the 2024 stock option incentive plan of Jinhe Biotechnology Co., Ltd. as submitted by Shanghai Xingonyihe Enterprise Management & Consulting Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.